Site Perspectives on Decentralized Clinical Trials
White Paper
Site Perspectives on Decentralized Clinical Trials
While DCT technologies have enabled patients and sites to participate in novel and innovative ways, there is a lack of qualitative and quantitative data on site perspectives on the use and implementation of these initiatives.
To examine how this model has impacted site experiences, Medidata partnered with SCRS to survey its members on a variety of DCT topics, including scope, perceived effectiveness, and enablement. Understanding clinical research sites’ experiences and perspectives on DCTs will help industry stakeholders – from sponsors and clinical research organizations (CROs) to regulatory agencies – refine trial design, operational procedures, and regulatory policy to better serve patients and sites while optimizing outcomes for the global health community.
Download the white paper for the insights uncovered by this research.
